The related Lilly drug tirzepatide lists hair loss as a common side effect on its approved label, and alopecia has also been reported in trials of the newer oral drug orforglipron, which is consistent with a class effect driven by weight loss rather than by one specific molecule
Whichever estimate we choose, a large number of U.S
Hodges H, Fealko C, Soares N
pylori virulence factors such as cytotoxin-associated gene A (CagA), vacuolating cytotoxin A (VacA), neutrophil-activating protein A (NapA), superoxide dismutase B (SodB), -glutamyl transpeptidase (gGT), lipopolysaccharide (LPS), and outer inflammatory protein A (OipA) affected glutathione (GSH), ROS, and lipid oxidation to regulate ferroptosis